XAGE on OTC

Longevity Health Holdings, Inc.

American soap company that raised $6 million in 2026 (SEC Form D). Summary from the record

Price unavailable

Last updated Oct 19, 2026.

Overview

Compare with Park Ha Biological Technology Co., Ltd., Meiwu Technology Co Ltd or Orion Bliss Corp., or pick any stock.

  • TickerXAGE on OTC1
  • IndustrySoap, Detergents, Cleang Preparations, Perfumes, Cosmetics1
  • HeadquartersPittsburgh, Pennsylvania1
  • Incorporated inDE2
  • Business address2403 Sidney Street, Suite 300, Pittsburgh, Pa 152032
  • Filer category, Emerging growth company2
  • Legal formCorporation

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

57.2%Gross margin3
-371.6%Operating margin3
-361.0%Net margin3
3701.4%Revenue growth, 20253
-$3.3MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue43¢$818.1K
  • Research and development41¢$788.9K
  • Other costs13¢$251.4K
  • Interest1¢$18.2K
  • Income tax2¢$36.3K

Out of $1.9M in revenue.3 The company lost money this year.

Financial statements

Revenue43$1.9M in 2025
0$500.0K$1.0M$1.5M$2.0M2023: $0$020232024: $50.3K$50.3K20242025: $1.9M$1.9M2025+3701%
Gross profit43$1.1M in 2025
0$500.0K$1.0M$1.5M2023: $0$020232024: $44.0K$44.0K20242025: $1.1M$1.1M2025+2390%
Operating income5643-$7.1M in 2025+1421% since 2021
-$8.0M-$6.0M-$4.0M-$2.0M02021: -$467.4K-$467.4K20212022: -$5.5M-$5.5M2022+1078%2023: -$5.9M-$5.9M2023+8%2024: -$5.0M-$5.0M2024−16%2025: -$7.1M-$7.1M2025+42%
Net income5643-$6.9M in 2025+1996% since 2021
-$20.0M-$15.0M-$10.0M-$5.0M02021: -$329.4K-$329.4K20212022: -$9.1M-$9.1M2022+2648%2023: -$15.4M-$15.4M2023+71%2024: -$10.4M-$10.4M2024−33%2025: -$6.9M-$6.9M2025−33%

Every line of the income statement as filed: the last 2 fiscal years, latest first.3

Period ending2025-12-312024-12-31
Gross sales$2.2M$90.8K
Discounts and allowances-$239.5K-$40.5K
Net sales$1.9M$50.3K
Cost of sales$818.1K$6.4K
Gross profit$1.1M$44.0K
Selling and marketing$1.4M$189.3K
Research and development$788.9K$1.1M
General and administrative$5.9M$3.7M
Depreciation and amortization of intangible assets$78.7K$83.5K
Total operating expenses$8.2M$5.0M
Loss from operations-$7.1M-$5.0M
Other income$168.1K$44.8K
Interest expense-$18.2K-$29.5K
Change in fair value of earnout liabilities$149.6K$0
Inventory write-down-$61.0K$0
Amortization of debt discount$0-$19.5K
Loss on forward purchase agreement$0-$5.7M
Loss on lease termination$0-$44.6K
Total other income (expense)$238.6K-$5.7M
Loss from continuing operations before income taxes-$6.9M-$10.7M
Income tax expense (benefit)$36.3K-$97.3K
Loss from continuing operations-$6.9M-$10.7M
Loss from discontinued operations, net of tax$0-$1.2M
Gain on sale of discontinued operations$0$1.4M
Net loss-$6.9M-$10.4M
Net loss from continuing operations - basic-$5-$15
Discontinued operations, net of tax - basic$0$0
Net loss per common share - basic-$4.83-$14.56
Net loss from continuing operations - diluted-$5-$15
Discontinued operations, net of tax - diluted$0$0
Net loss per common share - diluted-$4.83-$14.56
Weighted average of common shares outstanding , Basic1.4M shares712.1K shares
Weighted average of common shares outstanding, Diluted1.4M shares712.1K shares

Compare Longevity Health Holdings, Inc. with another company

Leadership

Who has led Longevity Health Holdings, Inc., and when. Pick a name to see everywhere that person has worked.

Board members and other officers (16)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Appointed as CEO and Chairman of the Board in connection with offering.Janakiram Ajjarapu named Mar 30, 202630
  • DirectorDavid S. Anderson named Apr 30, 202431

Former names

  • Carmell CorpAug 1, 2023 to Feb 13, 20252
  • ALPHA HEALTHCARE ACQUISITION CORP IIIFeb 2, 2021 to Jul 20, 20232

Timeline

  1. Apr 8, 2026New chief executive J. Ram Ajjarapu becomes CEO10
  2. Aug 8, 2024New chief executive Kendra Bracken-Ferguson becomes CEO11
  3. Jul 18, 2023New chief executive Randolph W. Hubbell becomes CEO12
  4. Jul 27, 2021New chief executive Rajiv Shukla becomes CEO13

Filings

301 filings to the SEC since October 2021: 8 annual reports, 16 quarterly reports, 59 major events, 91 insider forms, 29 large holders, 4 private raises, 94 other. The latest 20:

  1. Sep 8, 2026424B3 EDGAR
  2. Sep 8, 20268-K EDGAR
  3. Sep 8, 2026424B3 EDGAR
  4. Sep 4, 20268-K EDGAR
  5. Aug 17, 2026424B3 EDGAR
  6. Aug 17, 20268-K EDGAR
  7. Aug 14, 2026424B3 EDGAR
  8. Aug 14, 2026424B3 EDGAR
  9. Aug 14, 202610-Q EDGAR
  10. Aug 14, 20268-K EDGAR
  11. Jun 4, 20268-K EDGAR
  12. May 15, 2026424B3 EDGAR
  13. May 15, 202610-Q EDGAR
  14. Apr 8, 2026SCHEDULE 13D EDGAR
  15. Apr 8, 20264 EDGAR
  16. Apr 8, 20263 EDGAR
  17. Mar 31, 2026424B3 EDGAR
  18. Mar 31, 202610-K EDGAR
  19. Mar 30, 2026D EDGAR
  20. Mar 17, 20268-K EDGAR

The 301 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

125 open-market trades by officers, directors and large owners since October 2021: 125 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Mar 16, 2026Ajjarapu J. RamChief Executive OfficerBuy689,656$0.29$200.0KForm 4
Sep 13, 2024Upton Richard ADirectorBuy5,000$0.47$2.4KForm 4
Sep 10, 2024Cassaday Bryan J.Chief Financial OfficerBuy475$0.46$218Form 4
Sep 6, 2024Spenlehauer GillesDirectorBuy1,009$0.51$515Form 4
Sep 6, 2024Gregory KathrynDirectorBuy1,260$0.51$643Form 4
Sep 6, 2024Sturgeon Patrick ADirectorBuy1,261$0.51$643Form 4
Sep 6, 2024Frisch Scott M.DirectorBuy1,009$0.51$515Form 4
Aug 30, 2024Gregory KathrynDirectorBuy109$0.57$62Form 4
Aug 30, 2024Frisch Scott M.DirectorBuy87$0.57$50Form 4
Aug 30, 2024Sturgeon Patrick ADirectorBuy109$0.57$62Form 4
Aug 30, 2024Spenlehauer GillesDirectorBuy87$0.57$50Form 4
Aug 29, 2024Sturgeon Patrick ADirectorBuy652$0.56$365Form 4
Aug 29, 2024Gregory KathrynDirectorBuy652$0.56$365Form 4
Aug 29, 2024Spenlehauer GillesDirectorBuy522$0.56$292Form 4
Aug 29, 2024Frisch Scott M.DirectorBuy522$0.56$292Form 4
Aug 29, 2024Cassaday Bryan J.Chief Financial OfficerBuy1,000$0.57$570Form 4
Aug 29, 2024Anderson David WDirectorBuy652$0.56$365Form 4
Aug 28, 2024Sturgeon Patrick ADirectorBuy970$0.56$543Form 4
Aug 28, 2024Gregory KathrynDirectorBuy1,084$0.56$607Form 4
Aug 28, 2024Spenlehauer GillesDirectorBuy599$0.56$335Form 4

All 125 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Mar 16, 2026Raised $200,000 in a private offering of equity Form D: 1 investor so far Form D
  2. Jan 16, 2025Raised $975,463 in a private offering of equity Form D: $1.1 million offered in all Form D
  3. Jan 2, 2025Raised $1.9 million in a private offering of equity Form D: $3.7 million offered in all Form D
  4. Apr 11, 2024Raised $3 million in a private offering of equity Form D: 19 investors so far Form D

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
DRW Securities, LLC14,154$3.7K0.0%No change

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43